The former is currently awaiting FDA approval for a handful of oral, daily GLP-1 agonists, while the latter is developing combination therapies that use their muscle-preserving antibodies, trevogrumab and garetosmab, alongside GLP-1 drugs like Wegovy and Ozempic, to improve fat loss while preserving muscle mass
Systemic inflammation drives both metabolic dysfunction and neurological pain
Metabolism: Clinical and Experimental , 65 (3), 817
Retrieved from Zane, D., Feldman, P
Testosterone levels naturally decline with age, which may influence energy, muscle composition, mood and sexual wellness